DuPont de Nemours (NYSE:DD) Price Target Raised to $173.00

DuPont de Nemours (NYSE:DD – Get Free Report) had its price objective hoisted by investment analysts at Royal Bank Of Canada from $160.00 to $173.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm currently has an “outperform” rating on the basic materials company’s stock. Royal Bank Of Canada‘s price target would suggest a potential upside of 18.65% from the company’s previous close.

Other equities analysts have also issued research reports about the company. Wells Fargo & Company boosted their price objective on DuPont de Nemours from $166.00 to $170.00 and gave the stock an “overweight” rating in a research note on Thursday. UBS Group lifted their price target on DuPont de Nemours from $172.00 to $182.00 and gave the stock a “buy” rating in a report on Wednesday. JPMorgan Chase & Co. cut shares of DuPont de Nemours from an “overweight” rating to a “neutral” rating and lowered their price target for the company from $172.00 to $145.00 in a research report on Friday, October 9th. Barclays boosted their price target on shares of DuPont de Nemours from $156.00 to $176.00 and gave the company an “overweight” rating in a research report on Wednesday. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of DuPont de Nemours in a report on Friday, October 30th. Twelve equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $165.88.

Check Out Our Latest Stock Analysis on DD

DuPont de Nemours Price Performance

DD traded down $4.93 during trading on Thursday, reaching $145.80. The company’s stock had a trading volume of 991,607 shares, compared to its average volume of 1,348,562. The company has a market cap of $19.69 billion, a price-to-earnings ratio of 65.25, a PEG ratio of 1.37 and a beta of 1.06. The firm has a fifty day simple moving average of $132.93 and a two-hundred day simple moving average of $138.62. DuPont de Nemours has a 1 year low of $111.15 and a 1 year high of $157.98. The company has a quick ratio of 1.82, a current ratio of 2.36 and a debt-to-equity ratio of 0.23.

DuPont de Nemours (NYSE:DD – Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The basic materials company reported $2.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.87 by $0.22. DuPont de Nemours had a return on equity of 6.85% and a net margin of 4.26%. The business had revenue of $1.87 billion during the quarter, compared to analyst estimates of $1.84 billion. During the same period in the prior year, the business earned $1.09 earnings per share. The business’s revenue was up 4.1% compared to the same quarter last year. As a group, analysts anticipate that DuPont de Nemours will post 7.49 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of DD. State Street Corp raised its stake in shares of DuPont de Nemours by 140.3% in the 2nd quarter. State Street Corp now owns 44,941,824 shares of the basic materials company’s stock valued at $6,095,909,000 after acquiring an additional 26,238,300 shares during the period. Bank of America Corp DE boosted its position in shares of DuPont de Nemours by 22.0% during the 1st quarter. Bank of America Corp DE now owns 4,629,671 shares of the basic materials company’s stock worth $212,039,000 after purchasing an additional 835,572 shares during the period. Bank of New York Mellon Corp boosted its position in shares of DuPont de Nemours by 10.0% during the 1st quarter. Bank of New York Mellon Corp now owns 3,706,596 shares of the basic materials company’s stock worth $169,762,000 after purchasing an additional 336,780 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of DuPont de Nemours by 4.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 3,509,831 shares of the basic materials company’s stock worth $160,688,000 after purchasing an additional 163,210 shares during the period. Finally, Amundi increased its holdings in DuPont de Nemours by 31.3% in the 1st quarter. Amundi now owns 2,478,630 shares of the basic materials company’s stock valued at $113,526,000 after purchasing an additional 591,011 shares during the last quarter. Hedge funds and other institutional investors own 73.96% of the company’s stock.

Key DuPont de Nemours News

Here are the key news stories impacting DuPont de Nemours this week:

  • Positive Sentiment: DuPont reported third-quarter earnings and revenue above analyst expectations, with revenue up year over year, and raised its 2026 outlook. The earnings beat and improved guidance are key signs of stronger performance. DuPont rises as earnings beat estimates, company raises outlook
  • Positive Sentiment: Several firms lifted their price targets and maintained bullish ratings: Wells Fargo to $170 (Overweight), UBS to $182 (Buy), Citigroup to $176 (Buy), and Barclays to $176 (Overweight). These revisions signal increased analyst confidence in DD’s outlook. Wells Fargo price target
  • Neutral Sentiment: DuPont’s new peptide purification product may offer an opportunity in biopharmaceutical applications, though the article does not specify its likely near-term financial contribution. DuPont peptide purification product
  • Neutral Sentiment: The recent coverage is predominantly upbeat and provides no clear explanation for the latest share-price weakness; profit-taking after the earnings-driven rally is one possible explanation, but is not confirmed by the reports.

About DuPont de Nemours

(Get Free Report)

DuPont de Nemours, Inc is a diversified science and technology company that develops engineered materials and specialty products for industrial and consumer markets. Its offerings are used in applications including electronics, semiconductor manufacturing, water purification, transportation, construction, healthcare, and worker and consumer protection.

The company’s product portfolio has historically included high-performance films, resins, adhesives, engineered polymers, specialty fibers, protective materials, water-treatment membranes, and filtration technologies.

Read More

Analyst Recommendations for DuPont de Nemours (NYSE:DD)

Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.